GFAP and neoplasm: In the groups both with and without relapse, C5b-9 was frequently detected on GFAP-positive (tumor-specific) circulating EVs with high VEGF-A expression, whereas C5b-9 was significantly less frequently detected on EVs with low VEGF-A expression (p < 0.05).